-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Rani Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q2 2024.
- Rani Therapeutics Holdings, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.28M, a 0.79% increase year-over-year.
- Rani Therapeutics Holdings, Inc. Interest Expense for the twelve months ending June 30, 2024 was $5.18M, a 46.2% increase year-over-year.
- Rani Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $5.09M, a 375% increase from 2022.
- Rani Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $1.07M, a 130% increase from 2021.
- Rani Therapeutics Holdings, Inc. annual Interest Expense for 2021 was $466K, a 276% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)